Composition containing metal nanoparticles and preparation method and application thereof
By adjusting the characteristics of metal nanoparticle clusters and using stabilizer and coating technology, a composition with high absorption spectrum peak was prepared, which solved the problem of insufficient compatibility and signal intensity of gold nanoparticles in biomedical imaging, and achieved High signal enhancement and scalability for biomedical imaging.
Patent Information
- Application Number
- CN202380028761.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-01-19
- Filing Date
- 2023-01-18
- Publication Date
- 2024-11-05
AI Technical Summary
In biomedical imaging, existing gold nanoparticles have local surface plasmon resonance wavelengths located in the visible light spectrum, which is not compatible with the NIR-II window, and are insufficient in preparation and signal intensity, lack of scalability.
By adjusting the characteristics of metal nanoparticle clusters, including the number, diameter, shape and stacking method of nanoparticles in the cluster, combined with stabilizer and coating technology, a composition with high absorption spectrum peaks in the NIR-II window was prepared. Ensure it is evenly dispersed and stable in water.
The high signal enhancement and scalability of the composition is achieved, suitable for biomedical imaging, providing better optical properties and biocompatibility, and enhancing imaging effects.
Smart Images

Figure CN118900702A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of priority to U.S. Provisional Application No. 63 / 300,732, filed on January 19, 2022, the entire contents of which are incorporated herein by reference in their entirety. Technical Field
[0003] The present invention relates to a composition containing metal nanoparticles and a preparation method and use thereof. Background Art
[0004] Nanoparticles have a wide range of applications, including, for example, catalysis, energy materials / photonics, and imaging as contrast agents. Variations in the base material, reaction conditions, and surface chemistry of nanoparticles can alter their physical, chemical, and optical properties, making them extremely versatile contrast agents.
[0005] One use is as a contrast agent in biomedical imaging using the second near-infrared (NIR-II) window of about 1000nm to 1700nm, where photon penetration into the body is maximal due to minimal absorption and scattering by blood and tissue. This can allow for the capture of deep tissue, high signal-to-noise ratio images.
[0006] In medicine, spherical gold nanoparticles (AuNPs) are used in a variety of different imaging modalities, such as OCT, due to their excellent biocompatibility, physicochemical and plasmonic tunability, and targeting properties. One of the main drawbacks of conventional AuNPs (whether spherical or otherwise) is that their localized surface plasmon resonance wavelength (500nm-650nm) lies within the visible light spectrum, which means that it is incompatible with more commonly used imaging modalities that exploit biological imaging windows in the NIR-II window (>1000nm).
[0007] Recently, gold-based compositions with resonance wavelengths above 1000 nm have been proposed for biomedical applications, but such compositions suffer from a number of drawbacks, including lack of ease of preparation, scalability, and signal strength.
[0008] There are other metal plasmonic materials, such as copper sulfide and silver, that can reach these NIR-II wavelengths, but gold remains the standard due to its chemical inertness as well as good bioremoval properties.
[0009] Therefore, there is a need for improved compositions comprising nanoparticles. Summary of the invention
[0010] It is an object of the present invention to ameliorate at least some of the deficiencies present in the prior art. Embodiments of the present technology were developed based on the inventors' recognition that there is a need for improved compositions for imaging purposes that include nanoparticles.
[0011] The inventors have discovered that the optical absorption characteristics of a composition comprising metal nanoparticles can be customized by providing clusters of metal nanoparticles and adjusting the characteristics of the clusters to adjust the optical characteristics of the composition. The inventors have noted that adjusting the characteristics of the clusters, such as one or more of the following characteristics: the number of metal nanoparticles in each cluster, the diameter of each cluster, the shape of each cluster, the packing of metal nanoparticles within each cluster, and the size distribution of clusters in the carrier, can adjust the optical absorption of the composition. In certain embodiments, the composition can have optical characteristics that are shifted to the second near infrared (NIR-II) window.
[0012] Without being bound by any theory, the inventors hypothesize that such metal nanoparticle clusters can undergo large-scale plasmon hybridization, a phenomenon whereby the overall plasmon absorption band of a material red-shifts due to destructive interference when two or more plasmon fields are in close proximity.
[0013] Furthermore, the inventors have developed compositions comprising such clusters that are scalable, water-soluble, and uniformly distributed, and are therefore suitable for biomedical applications.
[0014] Unlike the reports on nanoparticle clusters in the prior art, these nanoparticle clusters consist of less than ten particles in close contact and the plasma red shift is less than 100 nm. (Liu X, et al. ChemPhysChem. 2007; 8(6): 906-912; Nguyen VP, et al. Nat Commun. 2021; 12(1): 34; Norman TJ, et al. J Phys Chem B. 2002; 106(28): 7005-7012; Kim J, et al. Nano Converg. 2020; 7(1): 5).
[0015] Turek et al. (Turek VA, et al. ACS Photonics. 2016; 3(1): 35-42)) used microemulsion technology to form gold superclusters, which, although appearing only as a shell of an emulsion core, produced optical properties similar to those of standard gold nanoparticles.
[0016] Kwon et al. (Kwon N, et al. Nano Lett. 2018; 18(9): 5927-5932) also demonstrated the formation of solvophobic gold superclusters using oleylamine-capped gold nanoparticles prepared in a flask in a hot oil bath, which aggregated upon addition of ethanol but dispersed in hexane or other organic solvents. Although these clusters showed absorbance in the NIR, they were extremely heterogeneous in size and shape distribution, could not be dispersed in water, and had no clear and well-defined NIR absorption peaks (probably due to the heterogeneity of size and shape in solution).
[0017] In addition, the inventors have developed methods for tailoring the size and shape of nanoparticle clusters using stabilizers and pre-capped solvents. Certain embodiments of such methods utilize the solvophobic effect as a driving force. Embodiments of these methods include "locking" the particle cluster morphology to ensure that the particle clusters are uniformly suspended in the carrier and can transfer the particle clusters to an aqueous solvent without loss of morphology.
[0018] From one aspect, a composition is provided, comprising a plurality of particle clusters in a carrier, at least one particle cluster comprising a plurality of metal nanoparticles, wherein at least one particle cluster is configured such that the composition has an absorption spectrum peak above about 900 nm.
[0019] In some embodiments, metal nanoparticles refer to particles with metallic properties, such as but not limited to metals, metal alloys or metal oxides. Nanoparticles refer to particles with a size range of about 1 nm to about 500 nm. In some embodiments, the size range of nanoparticles is about 1 nm to about 100 nm.
[0020] In certain embodiments, the metal nanoparticles include silver or gold particles.
[0021] In certain embodiments, at least one particle cluster comprises a coating. The coating comprises a polymer, which may be amphiphilic.
[0022] In certain embodiments, the size distribution of the plurality of particle clusters is substantially uniform. In certain embodiments, substantially uniform means that the composition has a polydispersity index of 0.3 or less as measured by transmission electron microscopy.
[0023] In certain embodiments, at least one particle cluster is water dispersible.
[0024] In certain embodiments, the carrier is an aqueous solution. The carrier can be physiological saline, water, or a 5% glucose aqueous solution. Such compositions can be used in biomedical applications.
[0025] In certain other embodiments, the carrier is a polar organic solvent.Such compositions can be used for non-biomedical applications.
[0026] In certain embodiments, each metal nanoparticle in at least one particle cluster is functionalized with a stabilizer. The stabilizer may comprise one or more of an amine, a thiol, or a carboxylic acid head group and a hydrophobic tail of any length and saturation. Optionally, the stabilizer is oleylamine, octadecene thiol, oleic acid, or a combination thereof.
[0027] In some embodiments, the configuration of at least one particle cluster comprises one or more of the following: a given number of metal nanoparticles in at least one particle cluster, a size of at least one particle cluster, a shape of at least one particle cluster, and a given packing of metal particles in at least one particle cluster. In some embodiments, at least one particle cluster comprises at least 3 layers of nanoparticles in the x, y, and z planes.
[0028] In certain embodiments, the composition has an absorbance spectrum between about 900 nm and about 1700 nm, between about 900 nm and about 1600 nm, between about 900 nm and about 1500 nm, between about 900 nm and about 1400 nm, between about 900 nm and about 1300 nm, between 950 nm and about 1700 nm, between about 950 nm and about 1600 nm, between about 950 nm and about 1500 nm, between about 950 nm and about 1400 nm, or between about 950 nm and about 1300 nm, between about 1000 nm and about 1700 nm, between about 1000 nm and about 1600 nm, between about 1000 nm and about 1500 nm, between about 1000 nm and about 1400 nm, and between about 1000 nm and about 1300 nm.
[0029] In certain embodiments, at least one particle cluster is substantially spherical.
[0030] In certain embodiments, the polymer comprises one or more of polyethylene glycol, polyvinyl chloride, poly-l-lysine, polylactic acid, poly(lactic acid-co-glycolic acid), polystyrene and polyvinyl pyrrolidone, and / or a block copolymer derived therefrom. In certain embodiments, the block copolymer is derived from polyethylene glycol. In certain embodiments, the block copolymer comprises a polyoxyalkylene having a saturated or unsaturated alkyl chain (e.g., BRIJ TM series); polyoxyethylene derivatives of saturated or unsaturated fatty acids and / or high molecular weight polyoxyethylene ethers having water solubility, surface activity and wetting properties (such as MYRJ TM series).
[0031] In certain embodiments, the coating comprises a plurality of coatings overlying at least one particle cluster. In certain embodiments where the coating comprises a hydrophilic polymer, a plurality of amphiphilic coatings are provided.
[0032] In certain embodiments, the composition further comprises a targeting agent attached to the surface of the particle cluster. In certain embodiments where there is a coating on the particle cluster, the targeting agent is attached to the coating (eg, an amphiphilic polymer).
[0033] In certain embodiments, the targeting agent comprises one or more of the following: a small molecule ligand, a peptide, a polymer, a nucleic acid construct (including DNA and RNA aptamers), a protein, a nanobody, an affibody, a minibody, a diabody, or an antibody.
[0034] In certain embodiments, the targeting agent binds to an intravascular inflammatory marker.
[0035] In certain embodiments, the targeting agent specifically binds to one or more of P-selectin, E-selectin, and VE-cadherin. In certain such embodiments, the targeting agent is a ligand for P-selectin, E-selectin, or VE-cadherin.
[0036] In certain embodiments, the targeting agent comprises a mixture of polymers, the mixture comprising a mixture ratio of fucose:sulfate (eg, 1:2), galactose:sulfate (eg, 1:2), or fucose:galactose:sulfate (eg, 1:1:1).
[0037] In certain embodiments, the average diameter of the particle clusters is from about 250 nm to about 1500 nm, or from about 300 nm to about 500 nm, or about 419 nm.
[0038] In certain embodiments, the metal nanoparticles are substantially spherical.
[0039] In certain embodiments, the average particle size of the metal nanoparticles ranges from about 2 nm to about 50 nm. In certain embodiments, the average particle size of the metal nanoparticles is about 9 nm.
[0040] From another aspect, a composition is provided, the composition comprising a plurality of particle clusters in a carrier, at least one of the plurality of particle clusters comprising a plurality of metal nanoparticles, each metal nanoparticle being functionalized with a stabilizer, wherein at least one particle cluster has a coating. In certain embodiments, the coating is a polymer, such as an amphiphilic polymer.
[0041] In certain embodiments, the configuration of the metal particles in at least one particle cluster is such that the composition has an absorption spectrum peak above about 900 nm.
[0042] In certain embodiments, the size distribution of the plurality of particle clusters is substantially uniform. In certain embodiments, substantially uniform means that the composition has a polydispersity index of 0.3 or less as measured by transmission electron microscopy.
[0043] In certain embodiments, at least one particle cluster is water dispersible. In certain embodiments, the carrier is an aqueous solution. In certain embodiments, the carrier is physiological saline, water, or a 5% dextrose solution in water.
[0044] In other embodiments, the carrier is a polar organic solvent.
[0045] In certain embodiments, the stabilizer comprises one or more of an amine, a thiol, a carboxylic acid head group, and a hydrophobic tail.
[0046] In certain embodiments, the configuration of nanoparticles in the particle clusters includes a given number of metal particles in at least one particle cluster and / or a given packing of metal particles in at least one particle cluster. In certain embodiments, at least one particle cluster contains at least 3 layers of nanoparticles in the x, y and z planes.
[0047] In certain embodiments, the composition has an absorbance spectrum between about 900 nm and about 1700 nm, between about 900 nm and about 1600 nm, between about 900 nm and about 1500 nm, between about 900 nm and about 1400 nm, between about 900 nm and about 1300 nm, between 950 nm and about 1700 nm, between about 950 nm and about 1600 nm, between about 950 nm and about 1500 nm, between about 950 nm and about 1400 nm, or between about 950 nm and about 1300 nm, between about 1000 nm and about 1700 nm, between about 1000 nm and about 1600 nm, between about 1000 nm and about 1500 nm, between about 1000 nm and about 1400 nm, and between about 1000 nm and about 1300 nm.
[0048] In certain embodiments, at least one particle cluster is substantially spherical.
[0049] In certain embodiments, the amphiphilic polymer comprises one or more of polyethylene glycol, polyvinyl chloride, poly-l-lysine, polylactic acid, PLGA, polystyrene, polyvinyl pyrrolidone, and / or block copolymers derived therefrom. In certain embodiments, the block copolymer is derived from polyethylene glycol, such as, but not limited to, polyoxyalkylenes having saturated or unsaturated alkyl chains (such as BRIJ TM series); polyoxyethylene derivatives of saturated or unsaturated fatty acids and / or high molecular weight polyoxyethylene ethers having water solubility, surface activity and wetting properties (such as MYRJ TM series).
[0050] In certain embodiments, the metal nanoparticles comprise particles that are generally metallic and may comprise, for example, a metal, a metal alloy, or a metal oxide. In certain embodiments, the metal nanoparticles comprise silver or gold particles.
[0051] In certain embodiments, multiple coatings on a particle cluster are provided.
[0052] In certain embodiments, the composition further comprises a targeting agent attached to the surface of the particle cluster or to a coating (eg, an amphiphilic polymer).
[0053] In certain embodiments, the targeting agent comprises one or more of the following: a small molecule ligand, a peptide, a polymer, a nucleic acid construct (including DNA and RNA aptamers), a protein, a nanobody, an affibody, a minibody, a diabody, or an antibody.
[0054] In certain embodiments, the targeting agent binds to an intravascular inflammatory marker.
[0055] In certain embodiments, the targeting agent specifically binds to one or more of P-selectin, E-selectin, and VE-cadherin. In certain such embodiments, the targeting agent is a ligand for P-selectin, E-selectin, or VE-cadherin.
[0056] In certain embodiments, the targeting agent comprises a mixture of polymers, the mixture comprising a mixture ratio of fucose:sulfate (eg, 1:2), galactose:sulfate (eg, 1:2), or fucose:galactose:sulfate (eg, 1:1:1).
[0057] In certain embodiments, the average diameter of the particle clusters is from about 250 nm to about 1500 nm, or from about 300 nm to about 500 nm.
[0058] In certain embodiments, the metal nanoparticles are substantially spherical.
[0059] In certain embodiments, the average particle size of the metal nanoparticles ranges from about 2 nm to about 50 nm. In certain embodiments, the average particle size of the metal nanoparticles is about 9 nm.
[0060] In certain embodiments, the compositions are suitable for use as contrast agents.
[0061] From another aspect, a method of preparing an embodiment of the composition described and / or claimed herein is provided. The method comprises: (i) reacting a metal nanoparticle precursor with a stabilizer to generate functionalized metal nanoparticles; (ii) dispersing the functionalized metal particles in a clustering agent to form metal particle clusters; and (iii) resuspending the metal particle clusters in a carrier to form a composition.
[0062] In certain embodiments, the metal nanoparticles are generally metallic and may include metals, metal alloys, or metal oxides.
[0063] The metal may comprise silver or gold, and the metal nanoparticle precursor may comprise a gold particle precursor or a silver particle precursor, respectively. In certain embodiments, the metal particle precursor is HAuCl4 or AgNO3.
[0064] In certain embodiments, the stabilizer comprises one or more of an amine, a thiol, or a carboxylic acid head group of any length and degree of saturation and a hydrophobic tail, optionally the stabilizer is oleylamine, octadecene thiol, oleic acid, or a combination thereof.
[0065] In some embodiments, the clustering agent is an organic solvent. The clustering agent can be one or more of the following: butanol, ethanol, petroleum ether or butanol-hexane. In some embodiments, the clustering agent can include a modified polymer or block copolymer containing hydrophobic and hydrophilic domains, such as but not limited to Pluronic TM Family members such as F127, MYRJ TM and / or BRIJ TM Family members such as polyethylene oxide (40) stearate and polyvinyl pyrrolidone.
[0066] In some embodiments, the reaction comprises heating the metal nanoparticle precursor together with a stabilizer. The heating may comprise microwave heating. In some other embodiments, the heating comprises one or more of oven heating, oil bath heating, water bath heating or heating mantle heating. In some embodiments, microwave heating can significantly shorten the reaction time of cluster formation.
[0067] In certain embodiments, the carrier in the composition is an aqueous solution, and the method further comprises separating the particle clusters from the clustering agent and suspending them in the aqueous solution.
[0068] In certain embodiments, separation is performed by centrifugation or precipitation. In other embodiments, separation is performed by size exclusion chromatography or magnetic separation.
[0069] In certain embodiments, the method further comprises coating the metal particle clusters with a coating.
[0070] From another aspect, a method of biomedical imaging is provided, the method comprising administering a contrast agent to a subject and imaging the contrast agent in the subject, wherein the contrast agent comprises a composition as described and / or claimed herein. In certain embodiments, the biomedical imaging comprises optical coherence tomography (OCT). OCT may include intravascular OCT.
[0071] In certain embodiments, imaging relies on NIR light having a wavelength of about 1000 nm to about 1700 nm.
[0072] In certain other embodiments, imaging relies on one or more of: (i) absorption of X-rays; (ii) diffraction of X-rays; (iii) absorption of light; and (iv) detection by an ultrasound transducer.
[0073] From another further aspect, there is provided a composition as described and / or claimed herein for use in imaging, such as biomedical imaging.
[0074] From another further aspect, there is provided a composition as described and / or claimed herein for use as a contrast agent. The contrast agent may be used when imaging using modalities such as OCT, X-ray, CT, synchrotron and photoacoustics.
[0075] From a further aspect, there is provided a contrast agent for biomedical imaging, the contrast agent comprising a composition as described and / or claimed herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0076] In order to better understand the present invention and more clearly explain how to implement the present invention, reference will now be made to the accompanying drawings by way of example, which illustrate various aspects and features of the present invention according to embodiments of the present invention, wherein:
[0077] Figure 1 is a flow chart of a method for preparing a composition containing metal nanoparticles according to certain embodiments of the present technology;
[0078] Figure 2 is a schematic diagram of a method for preparing a composition containing metal nanoparticles according to certain embodiments of the present technology;
[0079] Figure 3 shows the morphology and size distribution of particle clusters of metal nanoparticles in a composition according to certain embodiments of the present technology;
[0080] Figure 4 shows the aqueous size and dispersibility of particle clusters of metal nanoparticles in compositions according to certain embodiments of the present technology;
[0081] Figure 5 shows the absorption spectra of particle clusters of coated and uncoated metal nanoparticles in compositions according to certain embodiments of the present technology;
[0082] Figure 6 shows finite-difference time-domain simulation data of particle clusters of metal nanoparticles in compositions according to certain embodiments of the present technology;
[0083] Figure 7shows finite-difference time-domain simulation data of particle clusters of metal nanoparticles in a composition using a fixed unit cell according to certain embodiments of the present technology;
[0084] Figure 8 shows finite-difference time-domain simulation data of particle clusters of metal nanoparticles in compositions using varying unit cells according to certain embodiments of the present technology;
[0085] Fig. 9 shows finite-difference time-domain simulation data of particle clusters of metal nanoparticles in compositions using different coating thicknesses according to certain embodiments of the present technology;
[0086] Fig.10 shows a transmission electron microscope image and absorption spectrum of a composition comprising metal nanoparticle clusters in saline according to certain embodiments of the present technology;
[0087] Fig.11 shows an intravascular optical coherence tomography image of a composition comprising metal nanoparticle clusters in a carrier compared to reference gold nanoparticles according to certain embodiments of the present technology;
[0088] Fig.12 shows intravascular optical coherence tomography contrast enhancement of a composition comprising metal nanoparticle clusters in a carrier compared to a reference gold nanoparticle according to certain embodiments of the present technology;
[0089] Fig.13 shows an intravascular optical coherence tomography pullback image of a composition comprising metal nanoparticle clusters in a carrier in a vascular phantom, compared to a reference gold nanoparticle according to certain embodiments of the present technology;
[0090] Fig.14 shows an intravascular optical coherence tomography image of the abdominal aorta of a Sprague-Dawley rat, which was flushed sequentially with saline, a composition comprising metal nanoparticle clusters in a carrier, and again with saline according to certain embodiments of the present technology;
[0091] Fig.15A is a schematic diagram of a method for functionalizing a surface polymer of a gold particle cluster (AuSC) with a targeting ligand (1-3) according to certain embodiments of the present technology;
[0092] Fig. 15BTransmission electron micrographs of AuSC functionalized with different targeting ligand combinations as shown according to certain embodiments of the present technology are shown (left). The right figure shows the degree of binding of AuSC to P-selectin in vitro for different AuSC targeting formulations. *p<0.05, **p<0.01, ****p<0.001;
[0093] Fig. 15C Intravascular optical coherence tomography of the abdominal aorta of Sprague-Dawley rats after induction of intra-arterial inflammation before and after introduction of non-targeted AuSCs (left) or targeted AuSCs (center and right) is shown. According to certain embodiments of the present technology, the aorta is flushed sequentially with saline, a composition comprising metal nanoparticle clusters in a carrier, and again with saline;
[0094] Fig.15D shows the 400 MHz of FucoPEO synthesized prior to particle conjugation according to certain embodiments of the present technology 1 H NMR spectroscopy;
[0095] Fig.15E Shown is the 400 MHz of GalaPEO synthesized prior to particle conjugation according to certain embodiments of the present technology. 1 H NMR spectroscopy;
[0096] Fig.15F 400 MHz of SulfoPEO synthesized prior to particle conjugation according to certain embodiments of the present technology is shown. 1 H NMR spectroscopy;
[0097] Figure 15G The MALDI-TOF spectrum of FucoPEO is shown. According to certain embodiments of the present technology, the spectrum shows a central mass of M+Na, and other peaks are different ethylene oxide chain lengths with the same functionalization;
[0098] Fig.15H The MALDI-TOF spectrum of GalaPEO is shown. According to certain embodiments of the present technology, the spectrum shows a central mass of M+Na, and other peaks are different ethylene oxide chain lengths with the same functionalization; and
[0099] Fig.15I The MALDI-TOF spectrum of SulfoPEO is shown. According to certain embodiments of the present technology, the spectrum shows a central mass of M+Na, and other peaks are different ethylene oxide chain lengths with the same functionalization. DETAILED DESCRIPTION
[0100] In order to provide clear and consistent understanding of the terms used in this specification, some definitions are provided below. In addition, unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by ordinary technicians in the field to which the invention belongs.
[0101] In the claims and / or the specification, the term "a" used in conjunction with the term "comprising" may mean "one", but also means "one or more", "at least one" and "one or more". Similarly, the term "another" may mean at least one or more.
[0102] The words "comprising" (and any form of inclusion, such as "comprising" and "including"), "having" (and any form of having, such as "having" and "having"), "including" (and any form of inclusion, such as "including" and "including"), or "containing" (and any form of containing, such as "containing" and "containing") used in this specification and claims are inclusive or open-ended and do not exclude additional, uncited elements or process steps.
[0103] The term "about" is used to indicate that a value includes the inherent variation of error for the device or method being employed to determine the value.
[0104] "Derivative" and "variant" are used interchangeably herein.
[0105] Various aspects of the present technology include compositions having metal nanoparticle clusters in a carrier. The optical properties (e.g., absorption spectra) of the composition can be customized for a particular application by adjusting one or more cluster parameters, such as cluster diameter, the number of nanoparticles in the cluster, the packing of metal nanoparticles in the cluster, and the size or shape distribution of the clusters in the carrier. Various aspects of the present technology include methods for preparing such compositions.
[0106] Composition
[0107] In certain embodiments, the composition comprises particle clusters comprising metal nanoparticles in a carrier.
[0108] Metal nanoparticles and particle clusters
[0109] The metal nanoparticles may comprise any suitable metal particles, such as metal alloys, metal oxides, and pure metals. Example metals include, but are not limited to, gold, silver, copper, palladium, manganese oxide. The precursor of the gold particles may comprise HAuCl4.
[0110] In some embodiments, the diameter of the metal particles is in the range of about 1 to 100 nm, about 1 to about 90 nm, about 1 to about 80 nm, about 1 nm to about 70 nm, about 1 nm to about 60 nm, about 1 nm to about 50 nm, or about 2 nm to about 50 nm. In some embodiments, the metal nanoparticles comprise gold nanoparticles having a diameter of about 5-15 nm or about 9 nm.
[0111] The size distribution of metal nanoparticles in the cluster can be substantially uniform. For example, the diameter range of the metal nanoparticles can be between about 8nm and about 11nm, with a median and an average diameter of 9nm. In other embodiments, the size distribution of metal nanoparticles in the cluster can be substantially non-uniform. For example, the diameter of the metal nanoparticles can be between about 1nm and about 100nm.
[0112] In certain embodiments, the particle clusters in the composition are substantially spherical.
[0113] In certain embodiments, at least a portion of the particle clusters have a size range of about 250 nm to about 1500 nm, about 300 nm to about 1400 nm, about 300 nm to about 1300 nm, about 300 nm to about 1200 nm, about 300 nm to about 1100 nm, about 300 nm to about 1000 nm, about 300 nm to about 900 nm, about 300 nm to about 800 nm, about 400 nm to about 800 nm, about 500 nm to about 800 nm, about 300 nm to about 700 nm, about 300 nm to about 600 nm, about 300 nm to about 500 nm, about 400 nm to about 600 nm, or about 400 nm to about 500 nm.
[0114] The size of the particle clusters can be measured by any known method, such as image analysis of electron microscope images of the particle clusters, or using a particle size analyzer to measure the particle clusters in solution.
[0115] The size of the particle clusters is substantially uniform. In certain embodiments, substantially uniform means that the composition has a polydispersity index of 0.3 or less as measured by transmission electron microscopy.
[0116] The packing of metal nanoparticles can be defined as the inter-particle distance. In certain embodiments, the inter-particle distance is defined as the unit cell volume, and the distance between the unit cell corners represents the inter-particle distance between two metal nanoparticles.
[0117] For particle clusters containing gold nanoparticles, the unit cell can be assumed to be a face-centered cubic unit cell (i.e., the length of the unit cell in the x, y, and z directions is equal). The unit cell volume, and the packing of gold nanoparticles in the particle cluster, can be determined based on the measured dimensions of the particle cluster and the gold nanoparticles. The side length of the unit cell can be calculated as 2.828*the atomic radius of gold (144), which is calculated to be 0.4073nm.
[0118] In some embodiments, the packing of the metal nanoparticles is uniform in the supercluster. In other embodiments, the packing of the metal particles varies from the inner portion to the outer portion of the particle cluster. For example, the metal nanoparticles can be more densely packed in the inner portion of the particle cluster than in the outer portion of the particle cluster.
[0119] In some embodiments, the metal nanoparticles have a unit cell volume of 13 nm. 3 , 14nm 3 or 15nm 3 For example, the packing in the inner part of the particle cluster may contain 14 nm 3 The unit cell volume of the particle cluster can contain 15nm 3 In another embodiment, the packing of the metal particles extending radially from the inner portion to the outer portion may be graded, for example with a 13 nm 3 , 14nm 3 and 15nm 3 The unit cell volume.
[0120] The absorption spectrum of the composition is between about 900nm and about 1700nm, between about 900nm and about 1600nm, between about 900nm and about 1500nm, between about 900nm and about 1400nm, between about 900nm and about 1300nm, between about 950nm and about 1700nm, between about 950nm and about 1600nm, between about 950nm and about 1500nm, between about 950nm and about 1400nm, or between about 950nm and about 1300nm, between about 1000nm and about 1700nm, between about 1000nm and about 1600nm, between about 1000nm and about 1500nm, between about 1000nm and about 1400nm, between about 1000nm and about 1300nm. In certain embodiments, the absorption spectrum of the composition is above about 900nm.
[0121] The absorption spectrum of the composition has a peak wavelength between about 800 nm and 1400 nm, about 800 nm, about 900 nm, about 1000 nm, about 1100 nm, about 1200 nm, about 1300 nm, or about 1400 nm.
[0122] Absorption spectra, such as plasmon resonance spectroscopy, can be obtained using any suitable instrument and method, such as, but not limited to, visible near infrared spectrometers. The spectrum of the carrier can be subtracted from the spectrum of the entire composition.
[0123] In some embodiments, at least a portion of the metal nanoparticle clusters have a coating that encapsulates the clusters. Multiple coatings can be provided, such as 2, 3, or 4 coatings. The coating can include a polymer, a block copolymer, or a modified polymer. The coating can include an amphiphilic polymer. In some embodiments, the coating is polyoxyethylene (40) stearate (such as "Myrj 52").
[0124] In certain embodiments, the coating has a thickness of about 0.5 nm to about 10 nm. In certain embodiments, the coating has a thickness of less than about 1 nm.
[0125] The coating may comprise any suitable polymer, such as one or more of polyethylene glycol, polyvinyl chloride, poly-l-lysine, polylactic acid, poly(lactic-co-glycolic acid), polystyrene and polyvinylpyrrolidone. The coating may comprise a block copolymer, such as MYRJ TM and BRIJ TM Any member of the series, such as but not limited to polyoxyalkylenes having saturated or unsaturated alkyl chains (such as BRIJ TM series); polyoxyethylene derivatives of saturated or unsaturated fatty acids and / or high molecular weight polyoxyethylene ethers having water solubility, surface activity and wetting properties (such as MYRJ TM series).
[0126] In some embodiments, at least a portion of the clusters comprise metal nanoparticles functionalized with a stabilizer. In some embodiments, the stabilizer comprises one or more of: an amine, a thiol, or a carboxylic acid head group and a hydrophobic tail of any length and saturation, optionally, the stabilizer is oleylamine, octadecene thiol, oleic acid, or a combination thereof. In some embodiments, some clusters of the composition comprise 9 nm gold particles terminated with oleylamine.
[0127] In certain embodiments, a targeting agent attached to the surface of a particle cluster is provided. In certain embodiments where there is a coating on the particle cluster, the targeting agent is attached to the coating (e.g., an amphiphilic polymer). The targeting agent may comprise one or more of the following: a small molecule ligand, a peptide, a polymer, a nucleic acid construct (including DNA and RNA aptamers), a protein, a nanobody, an affibody, a minibody, a diabody, or an antibody.
[0128] The targeting agent can bind to an intravascular inflammatory marker. The targeting agent can bind to one or more of P-selectin, E-selectin, and VE-cadherin. The targeting agent can be a ligand of P-selectin, E-selectin, or VE-cadherin, such as, but not limited to, a mixture of polymers, such as and not limited to, a mixing ratio comprising fucose:sulfate (1:2), galactose:sulfate (1:2), or fucose:galactose:sulfate (1:1:1).
[0129] Carrier
[0130] The carrier may comprise any suitable carrier. In certain embodiments, the carrier comprises an aqueous solution, a cream or a gel. For biomedical use, the aqueous carrier may comprise one or more of physiological saline, water or a glucose solution.
[0131] In certain other embodiments, the carrier comprises an organic solvent.
[0132] method
[0133] refer to Figure 1 In certain aspects, a method for preparing a composition embodiment includes: (i) reacting a metal nanoparticle precursor with a stabilizer to generate functionalized metal nanoparticles; (ii) dispersing the functionalized metal particles in a clustering agent to form metal particle clusters; and (iii) resuspending the metal particle clusters in a carrier to form a composition.
[0134] Any suitable metal nanoparticle precursors, stabilizers, clustering agents, and supports can be used to generate metal nanoparticle clusters with different physical, optical, and chemical properties.
[0135] In certain embodiments, the metal nanoparticle precursor may include HAuCl4 or AgNO3. However, other metal salts are also possible as metal precursors.
[0136] In certain embodiments, the stabilizer may comprise one or more of an amine, a thiol, or a carboxylic acid head group of any length and degree of saturation and a hydrophobic tail. Optionally, the stabilizer is oleylamine, octadecene thiol, oleic acid, or a combination thereof.
[0137] In certain embodiments, the clustering agent is an organic solvent. Examples of clustering agents include, but are not limited to, butanol, ethanol, petroleum ether, butanol-hexane with or without pluronic F127, polyethylene oxide (40) stearate, and polyvinyl pyrrolidone.
[0138] In some embodiments, the reaction comprises heating the metal nanoparticle precursor together with the stabilizer. The heating can be carried out in any manner and at any suitable temperature, for any suitable length of time, sufficient to functionalize the metal particles with the stabilizer. The heating method is not particularly limited. For example, the heating can be one or more of microwave heating, oven heating, oil bath heating, water bath heating, or heating mantle heating.
[0139] In certain embodiments, the method further comprises applying a coating on the metal particle clusters. The coating may comprise a polymer, such as an amphiphilic polymer. The polymer may comprise one or more of polyethylene glycol, polyvinyl chloride, poly-l-lysine, polylactic acid, poly(lactic acid-co-glycolic acid), polystyrene and polyvinyl pyrrolidone. The polymer may comprise a modified polymer and / or a block copolymer thereof. The block copolymer may comprise a hydrophobic and a hydrophilic domain (i.e., amphiphilic), such as, but not limited to, members of the pluronic family such as F127, MYRJ TM and / or BRIJ TM Family members include polyethylene oxide (40) stearate and polyvinyl pyrrolidone. The coating step can be repeated to apply multiple coatings to the particle clusters.
[0140] In certain embodiments, the coating comprises multiple coatings on at least one particle cluster. In certain embodiments where the coating comprises an amphiphilic polymer, multiple amphiphilic coatings are provided. It has been found that adding polymer layers can increase the packing of particle clusters.
[0141] In certain embodiments, wherein the carrier in the composition is an aqueous carrier, the method further comprises separating the particle clusters from the clustering agent and suspending them in the aqueous carrier. The separation method can be one or more of centrifugation, precipitation, size exclusion chromatography or magnetic separation.
[0142] In certain embodiments, the method further comprises attaching a targeting agent to the surface of the particle cluster or to the coating (when there is a coating). The targeting agent can be any suitable agent, such as but not limited to a small molecule ligand, a peptide, a polymer, a nucleic acid construct (including DNA and RNA aptamers), a protein, a nanobody, an affinity antibody, a microantibody, a diabody or an antibody. The targeting system can bind to intravascular inflammatory markers such as P-selectin, E-selectin or VE-cadherin. For example and without limitation, the targeting agent can be a ligand of P-selectin, E-selectin or VE-cadherin, such as a mixture of polymers, such as a polymer mixture comprising a mixing ratio of fucose: sulfate (such as 1:2), galactose: sulfate (such as 1:2) or fucose: galactose: sulfate (such as 1:1:1).
[0143] In certain embodiments, the method comprises forming particle clusters of a given size by selecting a clustering agent with appropriate hydrophilicity. More specifically, the size of the particle clusters can be increased by selecting a clustering agent with higher hydrophilicity.
[0144] The use of the composition of the present technology is not limited and can include use as an imaging contrast agent, etc.
[0145] Example
[0146] The present invention will be more readily understood by reference to the following examples, which are provided for the purpose of illustrating the present invention and are not to be construed as limiting the scope thereof in any way.
[0147] Unless otherwise defined or the context clearly stipulates otherwise, all technical and scientific terms used herein have the same meaning as those commonly understood by one of ordinary skill in the art to which the invention belongs. It should be understood that any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention.
[0148] Example 1 - Gold-based particle clusters
[0149] refer to Figure 2 , in a three-necked flask, under stirring (950RPM), 40mM HAuCl4 ethylene glycol solution (4mL) (metal particle precursor) was added to 24.3mM oleylamine (8mL) (stabilizer) and 8mL of ethylene glycol. The two necks in the three-necked flask were covered with septa, and the middle neck was connected to a vacuum distillation adapter, which was connected to a vacuum and 5mL empty flask. The three-necked flask was heated to 43°C while applying vacuum, and the solution was stirred for ~30 minutes until all bubbles stopped. The flask was flushed with nitrogen and the vacuum adapter was removed. The solution (10mL) was carefully poured into two microwave reaction vessels flushed with nitrogen. The container was subjected to microwave synthesis in a chemical microwave oven (CEM Discover) (75W power heated to 115°C, then kept at this temperature for 90s, and cooled back to 50°C when released). The material in the container is poured into a 50mL Falcon tube, which is equipped with a 15g / L polyoxyethylene stearate (Myrj 52) n-butanol solution (coating). The solution is shaken overnight, centrifuged three times (1000×g, 10min, RT), resuspended in butanol (clustering agent) by ultrasonication in the first two centrifuges, and finally resuspended in a 40g / L polyoxyethylene stearate (Myrj 52) solution (coating) in ultrapure water by ultrasonication. This solution is shaken again overnight, centrifuged three times under the same conditions, and resuspended in fresh ultrapure water after each centrifugation. The final solution removes excess polymer by a size exclusion chromatography column (SEC). This final composition of the particle clusters contained in the suspension is stored at 4°C.
[0150] Figure 3 The morphology and size distribution of particle clusters throughout the cluster synthesis process in butanol are shown, with no polymer coating (A), a single polymer coating suspended in butanol (B), and two polymer coatings in water (C). The size distribution was obtained from two synthesis replicates of the clusters using the ImageJ automated particle size analyzer, with three counting areas per cluster on a transmission electron microscope grid.
[0151] Figure 4 Aqueous size and dispersibility of particle clusters prepared from gold nanoparticles and an amphiphilic polymer coating (AuSC@(Myrj 52)2) are shown. (A) Hydrodynamic size distribution of AuSC@(Myrj 52)2. (B) Zeta potential of AuSC@(Myrj 52)2. (C) Electrophoretic mobility of AuSC@(Myrj 52)2. All data are from triplicate readings of AuSC@(Myrj52)2 solutions in distilled water.
[0152] Example 2 - Tailoring the Optical Properties of Compositions
[0153] Optical properties of the particle clusters of Example 1 dispersed in butanol ( Figure 5 ), these particle clusters were compared without polymer coating (bare AuSC) and with one or two layers of polyethylene oxide (40) stearic acid polymer coating (AuSC@(Myrj 52), AuSC@Myrj 52)2, respectively). The particle clusters without polymer coating showed plasmon peaks similar to the unique peaks of known individual gold nanoparticles of about 9 nm (~550 nm), but with a red shift spanning from 550 nm to 700 nm ( Figure 5 A). The more prominent optical feature is the broad absorption peaks spanning from 800 nm to 1400 nm. These two peaks still exist in butanol after a single layer of polymer coating of the particle clusters (see Figure 5 A and B). When dispersed in water, the NIR peaks become clearer and more precise after further size focusing and aqueous shift in the AuSC@(Myrj5 2) 2 spectrum, although a large NIR broadband peak from 1000 to 1400 nm is still retained ( Figure 5 C).
[0154] We believe that the formation of the large NIR peak is the result of large-scale plasmonic hybridization throughout the 450 nm diameter particle cluster, which results in a red-shift in the plasmon band. Hybridization of such a large number of gold nanoparticles in close contact in one structure is responsible for a larger shift in the absorption band compared to the plasmonic hybridization red-shift reported previously in the literature. We believe that the unique optical properties of the double-coated gold particle clusters (AuSC@(Myrj 52)2) originate from a large number of assembled individual gold nanoparticles, which are composed entirely of tightly packed gold nanoparticles from the core to the surface. FIB-SEM images of AuSC@(Myrj 52)2 clusters confirm this assembly, where the superclusters were etched to reveal their core structure.
[0155] This example illustrates how the optical properties of a composition can be tailored by coating or uncoating the particle clusters.
[0156] Example 3. Computer simulation
[0157] To better understand how large-scale hybridization leads to the large NIR peaks of the dual-coated particle clusters (AuSC@(Myrj52)2) of Example 2, computer simulations of these particle clusters were performed using a finite-difference time-domain (FDTD) model with the goal of reproducing particle clusters with similar optical properties to those observed experimentally. Since no signals outside the standard gold nanoparticle unit cell are generated by X-ray diffraction evaluation, these simulations were also used to determine the volume of the unit cell that forms the particle clusters. We believe that the particle clusters are likely to self-assemble in a unit cell-like manner, similar to the molecular particles of gold nanoparticles. Since the unit cell volume ultimately determines the distance between particles, it helps to understand how the packing of gold nanoparticles affects the optical properties of the particle clusters. The simulated particle clusters were based on oleylamine-capped gold nanoparticles, which were driven to aggregate using an amphiphilic solvent. It is assumed that the simulated particle clusters were polymer-coated with polyethylene oxide (40) stearate in butanol and then coated in water, which may result in a higher degree of polymer coating on the gold nanoparticle components closer to the solvent-exposed surface, while the particles closer to the core of the particle cluster have a higher content of oleylamine. The surface inhomogeneity of the gold nanoparticle composition leads to inhomogeneity in the unit cell of the entire supercluster, with the core gold nanoparticles having smaller unit cells than the surface unit cells. When such gradient unit cell clusters are simulated in FDTD with two or three different unit cells, the resulting absorption spectra are almost identical to those observed experimentally. In particular, the use of 14 nm 3 The internal unit cell volume and 15nm 3 The external unit cell volume ( Figure 6 A) or 13nm from inside to outside 3 , 14nm 3 and 15nm 3 ( Figure 6The absorption spectra of the two different simulations of (B) are very similar. The absorption spectra of clusters with uniform unit cell volume are different from the experimental data ( Figure 7 ). The absorption and scattering components of the photophysical behavior of the simulated particle clusters were extracted from the extinction data, which showed that while scattering is the dominant interaction from visible to NIR wavelengths, there is still a large degree of light absorption in the visible range. Importantly, scattering is the dominant mode of light interaction in NIR-II. It is this dual mode of light interaction (i.e., absorption and scattering) across the visible-NIR-NIR-II spectrum that makes these clusters an interesting material with a wide range of uses. Figure 8 The finite-difference time-domain simulation data of AuSC@(Myrj 52)2 superclusters using different unit cells are shown. Each curve represents the unit cell volume range (from the inside to the outside) of the simulated particle cluster and the resulting extinction (absorption and scattering combined) spectrum. The simulated environment is a water environment, and there is a 10nm polymer (Myrj 52) coating around the particle cluster.
[0158] Fig. 9 Figure 4 shows finite-difference time-domain simulation data of a double polymer layer (AuSC@(Myrj 52)2) particle cluster using different polymer coating thicknesses. A 15 nm cluster consisting of 9 nm diameter gold nanoparticles was simulated using finite-difference time-domain measurements. 3 Unit cell. The surrounding simulated environment was water. Simulated polymer coatings up to 50 nanometers thick did not change the optical properties of the particle clusters.
[0159] Example 4 - Tailoring the optical properties of a composition using different stabilizers and different clustering agents
[0160] Table 1 shows different synthetic conditions for forming gold particle clusters, including reaction concentrations and conditions, operating steps, and the resulting absorption peaks and appearance of superclusters. It can be seen that the optical properties of the composition can be customized by adjusting the reagents used to prepare the composition.
[0161]
[0162]
[0163]
[0164]
[0165]
[0166]
[0167] Example 5 - Compositions for use as IV-OCT
[0168] Intravascular optical coherence tomography (IV-OCT) is commonly used in interventional cardiology assessments to image the health of coronary vessels and guide stent placement. However, IV-OCT is limited to anatomical imaging because contrast agents (agents that can provide specific signal enhancement) are not currently available. IV-OCT relies on backscattered, incoherent NIR-II light (central wavelength of approximately 1300nm), which is well suited for contrast enhancement of gold particle clusters. The composition of Example 1 was prepared, including double-coated particle clusters (AuSC@(Myrj 52)2) coated in a saline carrier. The strong ionic solvent had no effect on the structural and optical properties of the particle clusters ( Fig.10 ). Two-dimensional (2D) IV-OCT scans of particle clusters at different concentrations suspended in a glass pipette were performed to evaluate the contrast enhancement effect ( Fig.11 A commercial gold nanoparticle solution soluble in saline (mVivo, Medilumine Inc.) was used as a reference sample. Even after normalization for the total gold content in the solution, the IV-OCT signal enhancement produced by the composition was significantly higher (>10 times) than that produced by the reference gold nanoparticles ( Fig.11 ). Even microgram amounts of AuSC@(Myrj 52)2 produced a threefold signal enhancement. We also evaluated large discrete 500 nm gold nanoparticles (non-superclusters), which did not show a strong signal compared to AuSC@(Myrj 52)2 composite clusters (superclusters showed a ~1.8-fold signal enhancement compared to AuNPs, normalized to the number of particles in solution) ( Fig.12 ).
[0169] Particle clusters comprising metal nanoparticles of the present technology and gold nanoparticles in agarose suspension were used to prepare vascular phantoms ( Fig.13 ) to evaluate the more commonly used dynamic implementation of IV-OCT, which involves pulling back the imaging catheter through the vessel to generate longitudinal images ( Fig.13 ). The signal strength over the scan distance is plotted ( Fig.13 ), only the combined particle clusters produced contrast enhancement above background. The particle clusters also highlighted a large number of details within the agarose, such as bubbles and fractures, which were not easily discernible without the contrast agent.
[0170] The composition comprising AuSC@(Myrj 52)2 particle clusters was also used for in vivo imaging of the abdominal aorta (AA) of Sprague-Dawley rats ( Fig.14 AA was first rinsed with saline for imaging ( Fig.14 ), and then rinsed with 0.5 mg / mL AuSC@(Myrj52)2 saline solution for imaging ( Fig.14). The washed-out space showed a clear contrast with the signal generated by the AA wall. We then washed the AA with more saline to demonstrate that particles can be easily washed out of the field of view after imaging ( Fig.14 ).
[0171] By adding targeting groups specific for inflammatory markers to the surface of particle clusters, the difference in contrast before and after flushing can be used to detect intravascular inflammation before major morphological changes occur ( Fig.15A -I). The polymer coatings are easily functionalized with targeting groups that can bind biomolecular targets of interest (e.g., P-selectin, E-selectin, VE-cadherin, etc.), which are markers of intravascular inflammation, thereby enabling molecular imaging via IV-OCT ( Fig.15A ). The targeting agent can be a small molecule ligand, peptide, aptamer or antibody, which is linked to the polymer coating using a well-established mechanism (e.g., Ibrich K et al. Chem Rev. 2016; 116(9):5338-5431, the contents of which are incorporated herein by reference).
[0172] Fig. 15B Transmission electron micrographs of AuSCs functionalized with different targeting ligand combinations (left) and the extent to which AuSCs with different AuSc targeting agents bind to P-selectin in vitro (right) are shown. Fig. 15C Shown are intravascular optical coherence tomography scans of the abdominal aorta of Sprague-Dawley rats before and after introduction of untargeted AuSCs (left) or targeted AuSCs (center and right) following induction of intra-arterial inflammation, demonstrating successful targeting of AuSCs functionalized with targeting ligands.
[0173] Although the present invention is described in detail with reference to the embodiments of the present invention, these embodiments are provided to illustrate rather than limit the present invention. Other embodiments are designed according to the principles of the present invention, and these embodiments fall within the spirit and scope defined in the appended claims of the present invention.
[0174] The contents of all documents and references cited herein are incorporated by reference in their entirety.
Claims
1. A composition comprising a plurality of particle clusters in a carrier, at least one of the plurality of particle clusters comprising a plurality of metal nanoparticles, wherein the at least one particle cluster is configured so that the composition has an absorption peak above about 900 nm. 2 . The composition of claim 1 , wherein at least one particle cluster of the plurality of particle clusters has a coating.
3. The composition of claim 1 or 2, wherein the metal nanoparticles comprise silver or gold particles.
4. The composition of any one of claims 1-3, wherein the coating comprises a polymer.
5. The composition of any one of claims 1-4, wherein the plurality of particle clusters have a substantially uniform size distribution.
6. The composition of any one of claims 1-5, wherein the at least one particle cluster is water-dispersible.
7. The composition according to any one of claims 1 to 6, wherein the carrier is an aqueous solution or a polar organic solvent.
8. The composition of any one of claims 1-7, wherein each metal nanoparticle in the at least one particle cluster is functionalized with a stabilizer.
9. The composition of claim 8, wherein the stabilizer comprises one or more of an amine, a thiol, or a carboxylic acid head group and a hydrophobic tail of any length and degree of saturation, and optionally the stabilizer is oleylamine, octadecene thiol, oleic acid, or a combination thereof.
10. A composition according to any one of claims 1-9, wherein the configuration of the at least one particle cluster comprises a given number of the metal nanoparticles in the at least one particle cluster, a size of the particle cluster, a shape of the particle cluster and / or a given stacking of the metal nanoparticles in the at least one particle cluster.
11. The composition of any one of claims 1-10, wherein the composition has an absorbance spectrum between about 900 nm and about 1700 nm, about 900 nm and about 1600 nm, about 900 nm and about 1500 nm, about 900 nm and about 1400 nm, about 900 nm and about 1300 nm, 950 nm and about 1700 nm, about 950 nm and about 1600 nm, about 950 nm and about 1500 nm, about 950 nm and about 1400 nm, or about 950 nm and about 1300 nm, about 1000 nm and about 1700 nm, about 1000 nm and about 1600 nm, about 1000 nm and about 1500 nm, about 1000 nm and about 1400 nm, and about 1000 nm and about 1300 nm.
12. The composition of any one of claims 1-11, wherein the at least one particle cluster and / or the at least one metal nanoparticle is substantially spherical.
13. The composition of any one of claims 1-12, wherein the amphiphilic polymer comprises one or more of the following: polyethylene glycol, polyvinyl chloride, poly-L-lysine, polylactic acid, poly(lactic-co-glycolic acid), polystyrene, polyvinyl pyrrolidone, and modified polymers or block copolymers thereof.
14. The composition of any one of claims 1-12, wherein the coating comprises a plurality of coatings on the at least one particle cluster.
15. The composition according to any one of claims 1-14, further comprising a targeting agent attached to the surface of the particle cluster or the coating.
16. The composition of claim 15, wherein the targeting agent comprises one or more of the following: a small molecule ligand, a peptide, a polymer, a nucleic acid construct (including DNA and RNA aptamers), a protein, a nanobody, an affibody, a minibody, a diabody or an antibody.
17. The composition of claim 15 or 16, wherein the targeting agent binds to an intravascular inflammatory marker.
18. The composition of any one of claims 15-17, wherein the targeting agent specifically binds to one or more of P-selectin, E-selectin, and VE-cadherin.
19. The composition of any one of claims 15-18, wherein the targeting agent comprises a mixture of polymers comprising a mixing ratio of fucose:sulfate (1:2), galactose:sulfate (1:2), or fucose:galactose:sulfate (1:1:1).
20. The composition of any one of claims 1-19, wherein the average diameter of the particle clusters is from about 250 nm to about 1500 nm, or from about 300 nm to about 500 nm.
21. The composition of any one of claims 1-20, wherein the metal nanoparticles have an average particle size ranging from about 2 nm to about 50 nm.
22. The composition according to any one of claims 1 to 21, wherein the carrier is physiological saline, water or 5% dextrose in water.
23. A composition comprising a plurality of particle clusters in a carrier, at least one particle cluster of the plurality of particle clusters comprising a plurality of metal nanoparticles, each metal nanoparticle being functionalized with a stabilizer, and wherein the at least one particle cluster has a coating.
24. The composition of claim 23, wherein the at least one particle cluster is configured such that the composition has an absorption peak above about 900 nm.
25. The composition of claim 23 or 24, wherein the plurality of particle clusters have a substantially uniform size distribution.
26. The composition of any one of claims 23-25, wherein the at least one particle cluster is water dispersible.
27. The composition of any one of claims 23-25, wherein the carrier is an aqueous solution or a polar organic solvent.
28. The composition of any one of claims 23-27, wherein the stabilizer comprises one or more of: an amine, a thiol, a carboxylic acid head group, and a hydrophobic tail.
29. A composition according to any one of claims 23-28, wherein the configuration of the at least one particle cluster includes a given number of the metal particles in the at least one particle cluster, a size of the at least one particle cluster, a shape of the at least one particle cluster, and a given stacking of the metal nanoparticles in the at least one particle cluster.
30. The composition of any one of claims 23-29, wherein the composition has an absorbance spectrum between about 900 nm and about 1700 nm, between about 900 nm and about 1600 nm, between about 900 nm and about 1500 nm, between about 900 nm and about 1400 nm, between about 900 nm and about 1300 nm, between 950 nm and about 1700 nm, between about 950 nm and about 1600 nm, between about 950 nm and about 1500 nm, between about 950 nm and about 1400 nm, or between about 950 nm and about 1300 nm, between about 1000 nm and about 1700 nm, between about 1000 nm and about 1600 nm, between about 1000 nm and about 1500 nm, between about 1000 nm and about 1400 nm, and between about 1000 nm and about 1300 nm.
31. The composition of any one of claims 23-30, wherein the at least one particle cluster is substantially spherical.
32. The composition of any one of claims 23-31, wherein the amphiphilic polymer comprises one or more of the following: polyethylene glycol, polyvinyl chloride, poly-l-lysine, polylactic acid, PLGA, polystyrene, polyvinyl pyrrolidone and / or block copolymers or modified polymers derived therefrom.
33. The composition of any one of claims 23-32, wherein the metal nanoparticles comprise a metal composite, a metal alloy, or a metal oxide.
34. A composition according to any one of claims 23-33, wherein a plurality of coatings are provided around the particle clusters.
35. The composition of any one of claims 23-34, further comprising a targeting agent attached to the surface of the particle cluster or the coating.
36. The composition of claim 35, wherein the targeting agent comprises one or more of: a small molecule ligand, a peptide, a polymer, a nucleic acid construct (including DNA and RNA aptamers), a protein, a nanobody, an affibody, a minibody, a diabody, or an antibody.
37. The composition of claim 35 or 36, wherein the targeting agent binds to an intravascular inflammatory marker.
38. The composition of any one of claims 35-37, wherein the targeting agent specifically binds to one or more of P-selectin, E-selectin, and VE-cadherin.
39. The composition of any one of claims 35-38, wherein the targeting agent comprises a mixture of polymers comprising a mixing ratio of fucose:sulfate (1:2), galactose:sulfate (1:2), or fucose:galactose:sulfate (1:1:1).
40. The composition of any one of claims 23-39, wherein the average diameter of the particle clusters is from about 250 nm to about 1500 nm, or from about 300 nm to about 500 nm.
41. The composition of any one of claims 23-40, wherein the metal nanoparticles are substantially spherical.
42. The composition of any one of claims 23-41, wherein the metal nanoparticles have an average particle size ranging from about 2 nm to about 50 nm.
43. The composition according to any one of claims 23-42, wherein the carrier is physiological saline, water or 5% dextrose in water.
44. The composition of any one of claims 1-22 and claims 23-43, wherein the composition is suitable for use as a contrast agent.
45. A method for preparing a composition according to any one of claims 1 to 22 or claims 23 to 44, the method comprising: (i) reacting a metal nanoparticle precursor with a stabilizer to generate functionalized metal nanoparticles; (ii) dispersing the functionalized metal particles in a clustering agent to form particle clusters; as well as (iii) resuspending the particle clusters in a carrier to form the composition.
46. The method of claim 45, wherein the metal nanoparticle precursor is a gold particle precursor or a silver particle precursor.
47. The method of claim 46, wherein the metal particle precursor is HAuCl4 or AgNO3.
48. The method of any one of claims 45-47, wherein the stabilizer comprises one or more of an amine, a thiol, or a carboxylic acid head group and a hydrophobic tail of any length and degree of saturation, and optionally the stabilizer is oleylamine, octadecene thiol, oleic acid, or a combination thereof.
49. The method of any one of claims 45-48, wherein the clustering agent is an organic solvent.
50. The method according to any one of claims 45-49, wherein the clustering agent is one or more of the following: butanol, ethanol, petroleum ether, butanol-hexane.
51. The method of any one of claims 45-50, wherein the reacting comprises heating the metal nanoparticle precursor with the stabilizer.
52. The method of claim 51, wherein the heating is one or more of microwave heating, oven heating, oil bath heating, water bath heating, or heating mantle heating.
53. The method of any one of claims 45-52, wherein the carrier in the composition is an aqueous solution, the method further comprising separating the particle clusters from the clustering agent and suspending them in an aqueous solution.
54. The method of claim 53, wherein the separation is performed by one or more of centrifugation, sedimentation, size exclusion chromatography, or magnetic separation.
55. The method of any one of claims 45-54, further comprising coating the metal particle clusters in a coating.
56. A method of biomedical imaging, comprising administering a contrast agent to a subject and imaging the contrast agent in the subject, wherein the contrast agent comprises the composition of any one of claims 1-44.
57. The method of claim 56, wherein the biomedical imaging comprises optical coherence tomography (OCT).
58. The method of claim 57, wherein the OCT is intravascular OCT.
59. The method of any one of claims 56-58, wherein the imaging relies on NIR light having a wavelength of about 1000 nm to about 1700 nm.
60. The method of any one of claims 56-58, wherein the imaging relies on one or more of: (i) Absorption of X-rays; (ii) diffraction of X-rays; (iii) absorption of light; and (iv) Detection of ultrasonic transducers.
61. A composition according to any one of claims 1 to 44 for use in biomedical imaging.
62. A composition according to any one of claims 1 to 44 for use as a contrast agent.
63. A contrast agent for biomedical imaging comprising the composition of any one of claims 1 to 44.
